Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 4;13(9):2707.
doi: 10.3390/jcm13092707.

Prevention and Risk Assessment of Cardiac Device Infections in Clinical Practice

Affiliations
Review

Prevention and Risk Assessment of Cardiac Device Infections in Clinical Practice

Andrea Matteucci et al. J Clin Med. .

Abstract

The implantation of cardiac electronic devices (CIEDs), including pacemakers and defibrillators, has become increasingly prevalent in recent years and has been accompanied by a significant rise in cardiac device infections (CDIs), which pose a substantial clinical and economic burden. CDIs are associated with hospitalizations and prolonged antibiotic therapy and often necessitate device removal, leading to increased morbidity, mortality, and healthcare costs worldwide. Approximately 1-2% of CIED implants are associated with infections, making this a critical issue to address. In this contemporary review, we discuss the burden of CDIs with their risk factors, healthcare costs, prevention strategies, and clinical management.

Keywords: CIEDs infection; health care cost optimization; prevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Classification of CIEDs risk factors. CIEDs = cardiac implantable electronic devices; COPD = chronic obstructive pulmonary disease; HF = heart failure; NYHA = New York Heart Association.
Figure 2
Figure 2
Main prophylactic tools to be applied at all times to prevent CDIs.

References

    1. Clémenty N., Carion P.L., de Léotoing L., Lamarsalle L., Wilquin-Bequet F., Brown B., Verhees K.J.P., Fernandes J., Deharo J.-C. Infections and associated costs following cardiovascular implantable electronic device implantations: A nationwide cohort study. Europace. 2018;20:1974–1980. doi: 10.1093/europace/eux387. - DOI - PubMed
    1. Sohail M.R., Henrikson C.A., Braid-Forbes M.J., Forbes K.F., Lerner D.J. Increased long-term mortality in patients with cardiovascular implantable electronic device infections. Pacing Clin. Electrophysiol. 2015;38:231–239. doi: 10.1111/pace.12518. - DOI - PubMed
    1. Johansen J.B., Jørgensen O.D., Møller M., Arnsbo P., Mortensen P.T., Nielsen J.C. Infection after pacemaker implantation: Infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur. Heart J. 2011;32:991–998. doi: 10.1093/eurheartj/ehq497. - DOI - PMC - PubMed
    1. Da Costa A., Lelièvre H., Pha D., Kirkorian G., Célard M., Chevalier P., Vandenesch F., Etienne J., Touboul P. Role of the preaxillary flora in pacemaker infections. Circulation. 1998;97:1791–1795. doi: 10.1161/01.CIR.97.18.1791. - DOI - PubMed
    1. Uslan D.Z., Sohail M.R., Sauver JL S., Friedman P.A., Hayes D.L., Stoner S.M., Wilson W.R., Steckelberg L.M., Baddour L.M. Permanent pacemaker and implantable cardioverter defibrillator infection: A population-based study. Arch. Intern. Med. 2007;167:669–675. doi: 10.1001/archinte.167.7.669. - DOI - PubMed

LinkOut - more resources